Standardization of in vitro synthesis and detection of HIV-1-specific antibodies

Stefano Indraccolo, Rita Zamarchi, Maria Luisa Veronese, Maria Rosaria Mazza, Marta Mion, Arianna Veronesi, Marina Panozzo, Marco Colombatti, Andrea Barelli, Piero Rocchetto, Alberto Amadori, Luigi Chieco-Bianchi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Optical conditions for in vitro anti-human immunodeficiency virus type 1 (HIV-1) antibody (Ab) synthesis and detection were re-appraised. Western blot (WB) and radioimmunoassay (RIA) could detect about 1 and 10 ng, respectively, of HIV-1-specific Ab (HIV-Ab), while the sensitivity of an enzyme-linked immunosorbent assay (ELISA) was much lower. Optimal HIV-Ab recovery was obtained by culturing 2.5 × 106 peripheral blood mononuclear cells (PBMC)/ml from seropositive subjects for 16 days in the absence of mitogens; at higher cell concentrations, background levels were unacceptably high. The background of non-de novo synthesized HIV-Ab was due to insufficient PBMC washing and/or cytophilic immunoglobulin (Ig); a particular washing procedure, as well as 24 h peripheral blood mononuclear cells (PBMC) pre-culture, might help in limiting this phenomenon. However, results should be compared with those obtained in cultures containing puromycin especially in infants, where a higher CD16 antigen expression in lymphocytes is likely responsible for increased amounts of cytophilic Ig released in culture supernatants, compared to adults.

Original languageEnglish
Pages (from-to)105-115
Number of pages11
JournalJournal of Immunological Methods
Volume157
Issue number1-2
DOIs
Publication statusPublished - Jan 4 1993

Fingerprint

HIV-1
Blood Cells
Antibodies
Immunoglobulins
IgG Receptors
Puromycin
Mitogens
Radioimmunoassay
Cell Culture Techniques
Western Blotting
Enzyme-Linked Immunosorbent Assay
Lymphocytes
In Vitro Techniques

Keywords

  • (Antibody)
  • HIV-1
  • In vitro culture
  • Perinatal infection

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

Standardization of in vitro synthesis and detection of HIV-1-specific antibodies. / Indraccolo, Stefano; Zamarchi, Rita; Veronese, Maria Luisa; Mazza, Maria Rosaria; Mion, Marta; Veronesi, Arianna; Panozzo, Marina; Colombatti, Marco; Barelli, Andrea; Rocchetto, Piero; Amadori, Alberto; Chieco-Bianchi, Luigi.

In: Journal of Immunological Methods, Vol. 157, No. 1-2, 04.01.1993, p. 105-115.

Research output: Contribution to journalArticle

Indraccolo, S, Zamarchi, R, Veronese, ML, Mazza, MR, Mion, M, Veronesi, A, Panozzo, M, Colombatti, M, Barelli, A, Rocchetto, P, Amadori, A & Chieco-Bianchi, L 1993, 'Standardization of in vitro synthesis and detection of HIV-1-specific antibodies', Journal of Immunological Methods, vol. 157, no. 1-2, pp. 105-115. https://doi.org/10.1016/0022-1759(93)90076-J
Indraccolo, Stefano ; Zamarchi, Rita ; Veronese, Maria Luisa ; Mazza, Maria Rosaria ; Mion, Marta ; Veronesi, Arianna ; Panozzo, Marina ; Colombatti, Marco ; Barelli, Andrea ; Rocchetto, Piero ; Amadori, Alberto ; Chieco-Bianchi, Luigi. / Standardization of in vitro synthesis and detection of HIV-1-specific antibodies. In: Journal of Immunological Methods. 1993 ; Vol. 157, No. 1-2. pp. 105-115.
@article{fa6a3f5d07054fb694782db61a25acb6,
title = "Standardization of in vitro synthesis and detection of HIV-1-specific antibodies",
abstract = "Optical conditions for in vitro anti-human immunodeficiency virus type 1 (HIV-1) antibody (Ab) synthesis and detection were re-appraised. Western blot (WB) and radioimmunoassay (RIA) could detect about 1 and 10 ng, respectively, of HIV-1-specific Ab (HIV-Ab), while the sensitivity of an enzyme-linked immunosorbent assay (ELISA) was much lower. Optimal HIV-Ab recovery was obtained by culturing 2.5 × 106 peripheral blood mononuclear cells (PBMC)/ml from seropositive subjects for 16 days in the absence of mitogens; at higher cell concentrations, background levels were unacceptably high. The background of non-de novo synthesized HIV-Ab was due to insufficient PBMC washing and/or cytophilic immunoglobulin (Ig); a particular washing procedure, as well as 24 h peripheral blood mononuclear cells (PBMC) pre-culture, might help in limiting this phenomenon. However, results should be compared with those obtained in cultures containing puromycin especially in infants, where a higher CD16 antigen expression in lymphocytes is likely responsible for increased amounts of cytophilic Ig released in culture supernatants, compared to adults.",
keywords = "(Antibody), HIV-1, In vitro culture, Perinatal infection",
author = "Stefano Indraccolo and Rita Zamarchi and Veronese, {Maria Luisa} and Mazza, {Maria Rosaria} and Marta Mion and Arianna Veronesi and Marina Panozzo and Marco Colombatti and Andrea Barelli and Piero Rocchetto and Alberto Amadori and Luigi Chieco-Bianchi",
year = "1993",
month = "1",
day = "4",
doi = "10.1016/0022-1759(93)90076-J",
language = "English",
volume = "157",
pages = "105--115",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Standardization of in vitro synthesis and detection of HIV-1-specific antibodies

AU - Indraccolo, Stefano

AU - Zamarchi, Rita

AU - Veronese, Maria Luisa

AU - Mazza, Maria Rosaria

AU - Mion, Marta

AU - Veronesi, Arianna

AU - Panozzo, Marina

AU - Colombatti, Marco

AU - Barelli, Andrea

AU - Rocchetto, Piero

AU - Amadori, Alberto

AU - Chieco-Bianchi, Luigi

PY - 1993/1/4

Y1 - 1993/1/4

N2 - Optical conditions for in vitro anti-human immunodeficiency virus type 1 (HIV-1) antibody (Ab) synthesis and detection were re-appraised. Western blot (WB) and radioimmunoassay (RIA) could detect about 1 and 10 ng, respectively, of HIV-1-specific Ab (HIV-Ab), while the sensitivity of an enzyme-linked immunosorbent assay (ELISA) was much lower. Optimal HIV-Ab recovery was obtained by culturing 2.5 × 106 peripheral blood mononuclear cells (PBMC)/ml from seropositive subjects for 16 days in the absence of mitogens; at higher cell concentrations, background levels were unacceptably high. The background of non-de novo synthesized HIV-Ab was due to insufficient PBMC washing and/or cytophilic immunoglobulin (Ig); a particular washing procedure, as well as 24 h peripheral blood mononuclear cells (PBMC) pre-culture, might help in limiting this phenomenon. However, results should be compared with those obtained in cultures containing puromycin especially in infants, where a higher CD16 antigen expression in lymphocytes is likely responsible for increased amounts of cytophilic Ig released in culture supernatants, compared to adults.

AB - Optical conditions for in vitro anti-human immunodeficiency virus type 1 (HIV-1) antibody (Ab) synthesis and detection were re-appraised. Western blot (WB) and radioimmunoassay (RIA) could detect about 1 and 10 ng, respectively, of HIV-1-specific Ab (HIV-Ab), while the sensitivity of an enzyme-linked immunosorbent assay (ELISA) was much lower. Optimal HIV-Ab recovery was obtained by culturing 2.5 × 106 peripheral blood mononuclear cells (PBMC)/ml from seropositive subjects for 16 days in the absence of mitogens; at higher cell concentrations, background levels were unacceptably high. The background of non-de novo synthesized HIV-Ab was due to insufficient PBMC washing and/or cytophilic immunoglobulin (Ig); a particular washing procedure, as well as 24 h peripheral blood mononuclear cells (PBMC) pre-culture, might help in limiting this phenomenon. However, results should be compared with those obtained in cultures containing puromycin especially in infants, where a higher CD16 antigen expression in lymphocytes is likely responsible for increased amounts of cytophilic Ig released in culture supernatants, compared to adults.

KW - (Antibody)

KW - HIV-1

KW - In vitro culture

KW - Perinatal infection

UR - http://www.scopus.com/inward/record.url?scp=0027448314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027448314&partnerID=8YFLogxK

U2 - 10.1016/0022-1759(93)90076-J

DO - 10.1016/0022-1759(93)90076-J

M3 - Article

C2 - 8423352

AN - SCOPUS:0027448314

VL - 157

SP - 105

EP - 115

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -